Downloads

1. Next-Gen analytics for mRNA and LNPs: when traditional methods fall short 11/14/2025
2. Cell Bank And Scale Up Strategies For MSC And Exosome Manufacturing 10/9/2025

   Discover how effective cell banking and scale-up strategies can reduce risk and cost in advanced therapy manufacturing. Learn practical ways to meet increasing cell and exosome quantity needs.

3. What Can The Tech Sector's 'Minimally Viable' Concept Teach Biopharma? 10/9/2025

   Deciding what is good enough to get started can support the mindset of building something without sacrificing quality, functionality, or safety.

4. Deliver Potent Cell Therapies Faster, More Reliably And Enhance Cell Properties 10/8/2025

   Accelerate the next generation of cell-based therapies with innovative technologies that streamline manufacturing, enhance scalability, and expand patient access worldwide.

5. Overcoming Downstream Challenges In Next-Generation Antibody Development 10/8/2025

   Unlock expert strategies for navigating the complex downstream purification and process challenges inherent in developing next-generation antibodies. Design for scalability from the start.

6. Fermentation Of Live Biotherapeutic Products In cGMP Environments 10/8/2025

   We follow the journey from master cell bank to large-scale anaerobic fermentation, highlighting the unique needs for working with oxygen-sensitive, strictly anaerobic therapeutic microbes in a cGMP setting. 

7. Calculating The ROI Of EAM/CMMS For Pharma Manufacturers And CDMOs 10/6/2025

   Learn how modern EAM and CMMS systems help pharma manufacturers reduce risk, improve compliance, and cut costs, as well as nine signs it’s time to move beyond outdated asset management practices.

8. Higher Titers In Small-Cell Culture Systems And Bench-Scale Bioreactors 10/6/2025

   Accelerate your gene therapy development with a streamlined platform that simplifies vector production, reduces costs, and maintains high product quality from process design to clinical readiness.

9. Streamline Your AAV Process With A Production Platform 10/6/2025

   AAVs are reshaping gene therapy, but scaling production introduces complexity. Learn how upstream process optimization can improve yield, consistency, and speed to meet growing demands.

10. Survey: 30% Of Biopharmas Cite Cost, Productivity As Top Priorities 10/6/2025

    Both focus areas aim at the same outcome, stronger economics and sustainable competitiveness, according to BioPlan Associates' 22nd Annual Biomanufacturing Report.